Treprostinil Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
UTHR | B | United Therapeutics Corporation | -0.67 | |
ASND | D | Ascendis Pharma A/S | 0.25 | |
LQDA | D | Liquidia Technologies, Inc. | -3.37 |
Related Industries: Biotechnology
Related Stock Lists:
Hypertension
Pulmonary Arterial Hypertension
Biotechnology
Life Sciences
Alcohol
Biopharmaceutical
Blastoma
Brain Cancer
Breakthrough Therapy
Bupivacaine
Chemical Compounds
Chronic And Life Threatening Conditions
Clinical Trial
Diabetes
Disease
Drug Therapies
Growth Hormone
Growth Hormone Deficiency
Growth Hormone Therapy
Hepatitis C
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MEDI | D | Harbor Health Care ETF | 16.82 | |
PJP | A | PowerShares Dynamic Pharmaceuticals | 4.4 | |
BBP | D | BioShares Biotechnology Products Fund | 4.24 | |
SYNB | C | Putnam BioRevolution ETF | 3.93 | |
FTXH | D | First Trust Nasdaq Pharmaceuticals ETF | 3.88 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Hypertension
Pulmonary Arterial Hypertension
Biotechnology
Life Sciences
Alcohol
Biopharmaceutical
Blastoma
Brain Cancer
Breakthrough Therapy
Bupivacaine
Chemical Compounds
Chronic And Life Threatening Conditions
Clinical Trial
Diabetes
Disease
Drug Therapies
Growth Hormone
Growth Hormone Deficiency
Growth Hormone Therapy
Hepatitis C
- Treprostinil
Treprostinil (marketed under the trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles